NAMS

NewAmsterdam Pharma Company N.V.

Insider Trades

NameValueActionPriceCurrent Price
Topper James NDirector
$31k1.3k shares
BuySep 8, 2025
$24.99
--
Kooij Louise FrederikaChief Accounting Officer
$2.5M96.9k shares
SellSep 9, 2025
$26.11
--
Kooij Louise FrederikaChief Accounting Officer
$1.3M53.1k shares
SellSep 9, 2025
$25.31
--
Topper James NDirector
$16k660 shares
BuySep 15, 2025
$23.70
--
Kooij Louise FrederikaChief Accounting Officer
$1.5M43.9k shares
SellDec 26, 2025
$35.30
--
Kooij Louise FrederikaChief Accounting Officer
$2.7M75.1k shares
SellDec 23, 2025
$36.21
--

News

seekingalpha.comNewAmsterdam Pharma Company N.V. (NAMS) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcriptseekingalpha.comJun 10globenewswire.comNewAmsterdam Pharma Announces Upcoming Presentations at the National Lipid Association (NLA) 2026 Scientific Sessionsglobenewswire.comJun 3globenewswire.comNewAmsterdam Pharma to Participate at Upcoming Investor Conferences in Juneglobenewswire.comMay 28seekingalpha.comNewAmsterdam Pharma Company N.V. (NAMS) Presents at Bank of America Global Healthcare Conference 2026 Transcriptseekingalpha.comMay 13globenewswire.comNewAmsterdam Pharma to Participate at Upcoming Investor Conferences in Mayglobenewswire.comMay 11